» Articles » PMID: 29363047

New Perspectives on the Definition and Management of Polycystic Ovary Syndrome

Overview
Publisher Springer
Specialty Endocrinology
Date 2018 Jan 25
PMID 29363047
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is a growing debate on the opportunity of improving the understanding in the diagnosis and management of polycystic ovary syndrome (PCOS).

Objective: This review article summarizes recent research related to the definition of polycystic ovary syndrome (PCOS).

Methods: Review of the recent literature on the topic.

Results: New ideas on the definition of hyperandrogenism, based on new scientific data and clinical perspectives are presented. (i) In fact, recent studies have pointed out the need to improve the concept of androgen excess by using a larger androgen profile, rather than simply measuring the testosterone blood levels. (ii) Due to the poor correlation between androgen blood levels and the degree of hirsutism, it is proposed that the definition of hyperandrogenism should be based on the presence of blood androgen excess and hirsutism, considered separately, because their pathophysiological mechanisms may differ according to the different phenotypes of PCOS. (iii) The potential role of obesity in favoring the development of PCOS during adolescence is also discussed and the concept of "PCOS secondary to obesity" is developed. (iv) Finally, the need for greater appropriateness in the evaluation of possible coexistence is highlighted, in patients with PCOS who have fasting or glucose-stimulated very high insulin levels, or severe insulin-resistant states.

Conclusions: Based on what was discussed in this review, we believe that there are margins for modifying some of the current criteria that define the various PCOS phenotypes.

Citing Articles

A Randomized Trial of the Efficacy of Three Weight Loss Diet Interventions in Overweight/Obese with Polycystic Ovary Syndrome.

Dou P, Zhang T, Xu Y, Xue Q, Zhang Y, Shang J Endocr Metab Immune Disord Drug Targets. 2024; 24(14):1686-1697.

PMID: 38988067 DOI: 10.2174/0118715303286777240223074922.


Meta-analysis of the efficacy of ω-3 polyunsaturated fatty acids when treating patients with polycystic ovary syndrome.

Huang Y, Zhang X Medicine (Baltimore). 2023; 102(39):e35403.

PMID: 37773824 PMC: 10545389. DOI: 10.1097/MD.0000000000035403.


Idiopathic hirsutism: Is it really idiopathic or is it misnomer?.

Unluhizarci K, Hacioglu A, Taheri S, Karaca Z, Kelestimur F World J Clin Cases. 2023; 11(2):292-298.

PMID: 36686351 PMC: 9850967. DOI: 10.12998/wjcc.v11.i2.292.


A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).

Siddiqui S, Mateen S, Ahmad R, Moin S J Assist Reprod Genet. 2022; 39(11):2439-2473.

PMID: 36190593 PMC: 9723082. DOI: 10.1007/s10815-022-02625-7.


Health system-related needs for healthy nutritional behaviors in adolescent girls with polycystic ovary syndrome (PCOS): a qualitative study in Iran.

Hajivandi L, Noroozi M, Mostafavi F, Ekramzadeh M BMC Health Serv Res. 2022; 22(1):998.

PMID: 35932079 PMC: 9354299. DOI: 10.1186/s12913-022-08334-2.


References
1.
Franks S, Webber L, Goh M, Valentine A, White D, Conway G . Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries. J Clin Endocrinol Metab. 2008; 93(9):3396-402. DOI: 10.1210/jc.2008-0369. View

2.
Rosenfield R, Ehrmann D . The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016; 37(5):467-520. PMC: 5045492. DOI: 10.1210/er.2015-1104. View

3.
Tfayli H, Arslanian S . Menstrual health and the metabolic syndrome in adolescents. Ann N Y Acad Sci. 2008; 1135:85-94. PMC: 2723764. DOI: 10.1196/annals.1429.024. View

4.
Pfeifer M, Prezelj J, Kocijancic A . The correlation between clinical and hormonal parameters in androgenisation. Acta Eur Fertil. 1989; 20(1):31-3. View

5.
McCartney C, Blank S, Prendergast K, Chhabra S, Eagleson C, Helm K . Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls. J Clin Endocrinol Metab. 2006; 92(2):430-6. PMC: 2196134. DOI: 10.1210/jc.2006-2002. View